Naik also informed that research has been going on to develop and scientifically validate other herbal medicines to address other therapeutic groups like cancer, malaria, psychiatric and skin disorders etc

“Ayurvedic anti diabetic drug BGR-34 is scientifically tested and very effective in treating type 2 Diabetes,” said Shripad Naik, Union Minister of State, Ministry of AYUSH in the Rajya Sabha. Naik shared that the medicine has been launched in the market after undergoing all the required scientific tests. He further added that the drug has been successful in improving the blood glucose levels of the diabetes patients and is available on all major chemist counters across the country.

The anti-diabetic drug, BGR-34, has been in the market for about nine months now. It is developed and validated for its efficacy and safety by the scientists of National Botanical Research Institute (NBRI) and Central Institute of Medicinal and Aromatic Plants (CIMAP), the research units of Council of Scientific and Industrial Research (CSIR) and manufactured and marketed by Aimil Pharma.

KK Sharma, Managing Director, AIMIL Pharmaceuticals, said, “Naik’s statement on BGR-34’s efficacy will further enhance patients’ trust in the medicine. With a strong marketing distribution network spread all over the country, Aimil is strongly committed to carry forward the marvellous benefits of this novel research to the suffering masses all throughout the country and abroad thereby, helping them fight this ever challenging, fast increasing metabolic disorder known to be a silent killer, far more effectively and make them enjoy good quality healthy life.”

Post launch studies carried out on BGR-34 over the last one year have suggested its efficacy in treating pre-diabetic patients or for mild conditions like monotherapy as the drug effectively managed blood glucose homeostasis. In case of chronic and severe instances, it could be used as an adjuvant therapy to synthetic anti-diabetics. BGR-34 is found to provide valuable hepatoprotective, nephroprotective and dislipdemic activities to the advantage of diabetic patients.

Doctors from government and medical institutions including Dr Ramesh Kaushik, Rashtrapati Bhavan, Dr BP Gupta, Medical Superintendent, Aggarwal Hospital, Dr K Naval Mandora, Dr Sunil Kolhe and doctors from eminent government and renowned medical institutions like RML Hospital, Swami Dayanand Hospital, Hindu Rao Hospital etc. have also lent their support to BGR-34 for its efficacy, safety and inherent benefits in type-II diabetes. While speaking about the herbal medicines, Naik further added that research has been going on to develop and scientifically validate other herbal medicines to address more than 30 challenging therapeutic groups like cancer, malaria, psychiatric and skin disorders etc.

Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.